Last update 21 Nov 2024

SU-5220

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Neoasterriquinone
Target
EGFR x GRB2 x RAS
Mechanism
EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), GRB2 inhibitors(Growth factor receptor-bound protein 2 inhibitors), RAS inhibitors(RAS type GTPase family inhibitors)
Therapeutic Areas
Neoplasms
Active Indication-
Inactive Indication
Neoplasms
Originator Organization
MDS Pharma Services (US), Inc.MDS Pharma Services (US), Inc.
Active Organization-
Inactive Organization
University of Michigan Medical SchoolUniversity of Michigan Medical SchoolSugen, Inc.Sugen, Inc.MDS Pharma Services (US), Inc.MDS Pharma Services (US), Inc.
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Structure

Molecular FormulaC32H30N2O4
InChIKeyUVEJUMDZGOFSGL-UHFFFAOYSA-N
CAS Registry78860-48-7

Related

100 Clinical Results associated with SU-5220
Login to view more data
100 Translational Medicine associated with SU-5220
Login to view more data
100 Patents (Medical) associated with SU-5220
Login to view more data
1
Literatures (Medical) associated with SU-5220
01 Jan 1998The Journal of AntibioticsQ4 · MEDICINE
Studies on the Cytotoxicity of Asterriquinone Derivatives.
Q4 · MEDICINE
100 Deals associated with SU-5220
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
US
MDS Pharma Services (US), Inc.MDS Pharma Services (US), Inc.
-
NeoplasmsPreclinical
US
University of Michigan Medical SchoolUniversity of Michigan Medical School
-
NeoplasmsPreclinical
US
Sugen, Inc.Sugen, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free